Search

Your search keyword '"Piayda, Kerstin"' showing total 360 results
Start Over Author "Piayda, Kerstin"
360 results on '"Piayda, Kerstin"'

2. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry

Author

Vij, Vivian, Cruz-González, Ignacio, Galea, Roberto, Piayda, Kerstin, Nelles, Dominik, Vogt, Lara, Gloekler, Steffen, Fürholz, Monika, Meier, Bernhard, Räber, Lorenz, O’Hara, Gilles, Arzamendi, Dabit, Agudelo, Victor, Asmarats, Lluis, Freixa, Xavier, Flores-Umanzor, Eduardo, De Backer, Ole, Sondergaard, Lars, Nombela-Franco, Luis, McInerney, Angela, Salinas, Pablo, Korsholm, Kasper, Nielsen-Kudsk, Jens Erik, Afzal, Shazia, Zeus, Tobias, Operhalski, Felix, Schmidt, Boris, Montalescot, Gilles, Guedeney, Paul, Iriart, Xavier, Miton, Noelie, Saw, Jacqueline, Gilhofer, Thomas, Fauchier, Laurent, Veliqi, Egzon, Meincke, Felix, Petri, Nils, Nordbeck, Peter, Gonzalez-Ferreiro, Rocio, Bhatt, Deepak L., Laricchia, Alessandra, Mangieri, Antonio, Omran, Heyder, Schrickel, Jan Wilko, Rodes-Cabau, Josep, Nickenig, Georg, Sievert, Horst, and Sedaghat, Alexander

Published
2023
Full Text
View/download PDF

4. Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes

Author

Eppinger, Sophie, Piayda, Kerstin, Galea, Roberto, Sandri, Marcus, Maarse, Moniek, Güner, Ahmet, Karabay, Can Y., Pershad, Ashish, Ding, Wern Y., Aminian, Adel, Akin, Ibrahim, Davtyan, Karapet V., Chugunov, Ivan A., Marijon, Eloi, Rosseel, Liesbeth, Schmidt, Thomas Robert, Amabile, Nicolas, Korsholm, Kasper, Lund, Juha, Guerios, Enio, Amat-Santos, Ignacio J., Boccuzzi, Giacomo, Ellis, Christopher R., Sabbag, Avi, Ebelt, Henning, Clapp, Brian, Assa, Hana Vaknin, Levi, Amos, Ledwoch, Jakob, Lehmann, Sonja, Lee, Oh-Hyun, Mark, George, Schell, Wendy, della Rocca, Domenico G., Natale, Andrea, de Backer, Ole, Kefer, Joelle, Esteban, Pablo P., Abelson, Mark, Ram, Pradhum, Moceri, Pamela, Galache Osuna, Jose G., Alvarez, Xavier Millán, Cruz-Gonzalez, Ignacio, de Potter, Tom, Ghassan, Moubarak, Osadchiy, Andrey, Chen, Weita, Goyal, Sandeep K., Giannini, Francesco, Rivero-Ayerza, Máximo, Afzal, Shazia, Jung, Christian, Skurk, Carsten, Langel, Martin, Spence, Mark, Merkulov, Evgeny, Lempereur, Mathieu, Shin, Seung Y., Mesnier, Jules, McKinney, Heather L., Schuler, Brian T., Armero, Sebastien, Gheorghe, Livia, Ancona, Marco B.M., Santos, Lino, Mansourati, Jacques, Nombela-Franco, Luis, Nappi, Francesco, Kühne, Michael, Gaspardone, Achille, van der Pals, Jesper, Montorfano, Matteo, Fernández-Armenta, Juan, Harvey, James E., Rodés-Cabau, Josep, Klein, Norbert, Sabir, Sajjad A., Kim, Jung-Sun, Cook, Stephane, Kornowski, Ran, Saraste, Antti, Nielsen-Kudsk, Jens E., Gupta, Dhiraj, Boersma, Lucas, Räber, Lorenz, Sievert, Kolja, Sievert, Horst, and Bertog, Stefan

Published
2024
Full Text
View/download PDF

5. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

Author

Ajmone-Marsan, Nina, Alessandrini, Hannes, Badano, Luigi, Bartko, Philipp, Bax, Jeroen, Bazire, Baptiste, Benfari, Giovanni, Bernick, Jordan, Bohbot, Yohan, Carnero-Alcazar, Manuel, Chan, Vincent, Coisne, Augustin, Crestanello, Juan, De Bonis, Michele, Doguet, Fabien, Donal, Erwan, Dreyfus, Julien, Eggenspieler, Florian, Enriquez-Sarano, Maurice, Eixerés-Esteve, Andrea, Loureiro, Rodrigo Estevez, Eyharts, Damien, Fam, Neil, Flagiello, Michele, Galloo, Xavier, Gavazzoni, Mara, Habib, Gilbert, Hahn, Rebecca, Hausleiter, Jörg, Heitzinger, Gregor, Himbert, Dominique, Iliadis, Christos, Iung, Bernard, Juarez-Casso, Fernando, Kresoja, Karl-Patrick, Latib, Azeem, Lauten, Alexander, Lavie-Badie, Yoan, Le Tourneau, Thierry, Lim, Pascal, Lubos, Edith, Lurz, Philipp, Maisano, Francesco, Mbaki, Yannick, Michelena, Hector, Modine, Thomas, Messika-Zeitoun, David, Muraru, Denisa, Nejjari, Mohammed, Nickenig, Georg, Nicol, Martin, Nombela-Franco, Luis, Obadia, Jean-François, Omran, Hazem, Pedrazzini, Giovanni, Pfister, Roman, Piayda, Kerstin, Praz, Fabien, Radu, Costin, El Idrissi, Kenza Rahmouni, Riant, Elisabeth, Rodés-Cabau, Josep, Rudolph, Volker, Ruf, Tobias, Russo, Giulio, Sala, Alessandra, Schofer, Joachim, Selton-Suty, Christine, Senage, Thomas, Sievert, Horst, Stolz, Lukas, Tang, Gilbert H.L., Taramasso, Maurizio, Tomasi, Jacques, Topilsky, Yan, Tribouilloy, Christophe, Viau, Florence, von Bardeleben, Ralph Stephan, Webb, John, Weber, Marcel, Wells, George A., Windecker, Stephan, Zamorano, Jose Luis, Kresoja, Karl-Patrik, and Estevez Loureiro, Rodrigo

Published
2024
Full Text
View/download PDF

6. Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE

Author

Adamo, Marianna, Russo, Giulio, Pagnesi, Matteo, Pancaldi, Edoardo, Alessandrini, Hannes, Andreas, Martin, Badano, Luigi P., Braun, Daniel, Connelly, Kim A., Denti, Paolo, Estevez-Loureiro, Rodrigo, Fam, Neil, Gavazzoni, Mara, Hahn, Rebecca T., Harr, Claudia, Hausleiter, Joerg, Himbert, Dominique, Kalbacher, Daniel, Ho, Edwin, Latib, Azeem, Lubos, Edith, Ludwig, Sebastian, Lupi, Laura, Lurz, Philipp, Monivas, Vanessa, Nickenig, Georg, Pedicino, Daniela, Pedrazzini, Giovanni, Pozzoli, Alberto, Marafon, Denise Pires, Pastorino, Roberta, Praz, Fabien, Rodes-Cabau, Joseph, Besler, Christian, Schöber, Anne Rebecca, Schofer, Joachim, Scotti, Andrea, Piayda, Kerstin, Sievert, Horst, Tang, Gilbert H.L., Sticchi, Alessandro, Messika-Zeitoun, David, Thiele, Holger, Schlotter, Florian, von Bardeleben, Ralph Stephan, Webb, John, Dreyfus, Julien, Windecker, Stephan, Leon, Martin, Maisano, Francesco, Metra, Marco, and Taramasso, Maurizio

Published
2024
Full Text
View/download PDF

7. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale

Author

Kedhi, Elvin, Rroku, Andi, Hermanides, Rik S., Dambrink, Jan Henk, Singh, Sandeep, Berg, Jurriën Ten, van Ginkel, Dirk-Jan, Hudec, Martin, Amoroso, Giovanni, Amat-Santos, Ignacio J., Andreas, Martin, Teles, Rui Campante, Bonnet, Guillaume, Van Belle, Eric, Conradi, Lenard, van Garsse, Leen, Wojakowski, Wojtek, Voudris, Vasileious, Sacha, Jerzy, Cervinka, Pavel, Lipsic, Erik, Somi, Samer, Nombela-Franco, Luis, Postma, Sonja, Piayda, Kerstin, De Luca, Giuseppe, Malinofski, Krzysztof, and Modine, Thomas

Published
2024
Full Text
View/download PDF

8. Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion Catheter

Author

Bertog, Stefan C., Sharma, Alok, Hering, Dagmara, Mahfoud, Felix, Pathak, Atul, Schmieder, Roland E., Sievert, Kolja, Papademetriou, Vasilios, Weber, Michael A., Piayda, Kerstin, Lobo, Melvin D., Saxena, Manish, Kandzari, David E., Fischell, Tim A., Sievert, Horst, Heuser, Richard R., editor, Schlaich, Markus P., editor, Hering, Dagmara, editor, and Bertog, Stefan C., editor

Published
2023
Full Text
View/download PDF

9. Appraisal of Randomized Sham-Controlled Trial Data on Renal Denervation for the Management of Hypertension

Author

Bertog, Stefan C., Myat, Aung, Sharma, Alok, Sievert, Kolja, Piayda, Kerstin, Grunwald, Iris, Reinartz, Markus, Vogel, Anja, Pamela, Iloska, Galeru, Natalia, Steffan, Judith Anna Luisa, Sell, Gerhard, Raab, Johann, Starck, Erhard, Zeiher, Andreas, Stelter, Wolfgang, Hering, Dagmara, Bhatt, Deepak L., Sievert, Horst, Heuser, Richard R., editor, Schlaich, Markus P., editor, Hering, Dagmara, editor, and Bertog, Stefan C., editor

Published
2023
Full Text
View/download PDF

12. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry

Author

Vij, Vivian, Piayda, Kerstin, Nelles, Dominik, Gloekler, Steffen, Galea, Roberto, Fürholz, Monika, Meier, Bernhard, Valgimigli, Marco, O’Hara, Gilles, Arzamendi, Dabit, Agudelo, Victor, Asmarats, Lluis, Freixa, Xavier, Flores-Umanzor, Eduardo, De Backer, Ole, Sondergaard, Lars, Nombela-Franco, Luis, McInerney, Angela, Korsholm, Kasper, Nielsen-Kudsk, Jens Erik, Afzal, Shazia, Zeus, Tobias, Operhalski, Felix, Schmidt, Boris, Montalescot, Gilles, Guedeney, Paul, Iriart, Xavier, Miton, Noelie, Saw, Jacqueline, Gilhofer, Thomas, Fauchier, Laurent, Veliqi, Egzon, Meincke, Felix, Petri, Nils, Nordbeck, Peter, Ognerubov, Dmitrii, Merkulov, Evgeny, Cruz-González, Ignacio, Gonzalez-Ferreiro, Rocio, Bhatt, Deepak L., Laricchia, Alessandra, Mangieri, Antonio, Omran, Heyder, Schrickel, Jan Wilko, Rodes-Cabau, Josep, Sievert, Horst, Nickenig, Georg, and Sedaghat, Alexander

Published
2022
Full Text
View/download PDF

14. Impact of gender in patients with device-related thrombosis after left atrial appendage closure -- a sub-analysis from the multicenter EUROC-DRT-registry

Author

Saw, Jacqueline, primary, Vij, Vivian, additional, Galea, Roberto, additional, Piayda, Kerstin, additional, Nelles, Dominik, additional, Vogt, Lara, additional, Gloekler, Steffen, additional, Fürholz, Monika, additional, Meier, Bernhard, additional, Räber, Lorenz, additional, O'Hara, Gilles, additional, Arzamendi, Dabit, additional, Agudelo, Victor, additional, Asmarats, Lluis, additional, Freixa, Xavier, additional, Flores-Umanzor, Eduardo J, additional, Backer, Ole De, additional, Sondergaard, Lars, additional, Franco, Luis Nombela, additional, Salinas, Pablo, additional, Korsholm, Kasper, additional, Nielsen-Kudsk, Jens Erik, additional, Zeus, Tobias, additional, Operhalski, Felix, additional, Schmidt, Boris, additional, Montalescot, Gilles, additional, Guedeney, Paul, additional, Iriart, Xavier, additional, Miton, Noelie, additional, Gilhofer, Thomas, additional, Fauchier, Laurent, additional, Veliqi, Egzon, additional, Meincke, Felix, additional, Petri, Nils, additional, Nordbeck, Peter, additional, Gonzalez-Ferreiro, Rocio, additional, Cruz-González, Ignacio, additional, L, Deepak Bhatt, additional, Laricchia, Alessandra, additional, Mangieri, Antonio, additional, Omran, Heyder, additional, Schrickel, Jan Wilko, additional, Beiert, Thomas, additional, Rodes-Cabau, Josep, additional, Nickenig, Georg, additional, Sievert, Horst, additional, Sedaghat, Alexander, additional, and Afzal, Shazia, additional

Published
2024
Full Text
View/download PDF

18. Multiparametric MRI identifies subtle adaptations for demarcation of disease transition in murine aortic valve stenosis

Author

Quast, Christine, Kober, Frank, Becker, Katrin, Zweck, Elric, Hoffe, Jasmina, Jacoby, Christoph, Flocke, Vera, Gyamfi-Poku, Isabella, Keyser, Fabian, Piayda, Kerstin, Erkens, Ralf, Niepmann, Sven, Adam, Matti, Baldus, Stephan, Zimmer, Sebastian, Nickenig, Georg, Grandoch, Maria, Bönner, Florian, Kelm, Malte, and Flögel, Ulrich

Published
2022
Full Text
View/download PDF

21. Impact of gender in patients with device‐related thrombosis after left atrial appendage closure – A sub‐analysis from the multicenter EUROC‐DRT‐registry.

Author

Saw, Jacqueline, Vij, Vivian, Galea, Roberto, Piayda, Kerstin, Nelles, Dominik, Vogt, Lara, Gloekler, Steffen, Fürholz, Monika, Meier, Bernhard, Räber, Lorenz, O'Hara, Gilles, Arzamendi, Dabit, Agudelo, Victor, Asmarats, Lluis, Freixa, Xavier, Flores‐Umanzor, Eduardo, De Backer, Ole, Sondergaard, Lars, Nombela‐Franco, Luis, and Salinas, Pablo

Subjects
THROMBOSIS risk factors, RISK assessment, PROSTHETICS, ANTICOAGULANTS, SEX distribution, ARTIFICIAL implants, DESCRIPTIVE statistics, REPORTING of diseases, VITAMIN K, SURGICAL complications, KAPLAN-Meier estimator, ATRIAL fibrillation, LEFT atrial appendage closure, ADVERSE health care events, CONFIDENCE intervals, STROKE, COMORBIDITY, CHEMICAL inhibitors
Abstract

Background: Device‐related thrombosis (DRT) is a common finding after left atrial appendage closure (LAAC) and is associated with worse outcomes. As women are underrepresented in clinical studies, further understanding of sex differences in DRT patients is warranted. Methods and Results: This sub‐analysis from the EUROC‐DRT‐registry compromises 176 patients with diagnosis of DRT after LAAC. Women, who accounted for 34.7% (61/176) of patients, were older (78.0 ± 6.7 vs. 74.9 ± 9.1 years, p =.06) with lower rates of comorbidities. While DRT was detected significantly later in women (173 ± 267 vs. 127 ± 192 days, p =.01), anticoagulation therapy was escalated similarly, mainly with initiation of novel oral anticoagulant (NOAC), vitamin K antagonist (VKA) or heparin. DRT resolution was achieved in 67.5% (27/40) of women and in 75.0% (54/72) of men (p =.40). In the remaining cases, an intensification/switch of anticoagulation was conducted in 50.% (9/18) of men and in 41.7% (5/12) of women. Final resolution was achieved in 72.5% (29/40) cases in women, and in 81.9% (59/72) cases in men (p =.24). Women were followed‐up for a similar time as men (779 ± 520 vs. 908 ± 687 days, p =.51). Kaplan–Meier analysis revealed no difference in mortality rates in women (Hazard Ratio [HR]: 1.73, 95%‐Confidence interval [95%‐CI]:.68–4.37, p =.25) and no differences in stroke (HR:.83, 95%‐CI:.30–2.32, p =.72) within 2 years after LAAC. Conclusion: Evaluation of risk factors and outcome revealed no differences between men and women, with DRT in women being diagnosed significantly later. Women should be monitored closely to assess for DRT formation/resolution. Treatment strategies appear to be equally effective. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion

Author

Simard, Trevor, Jung, Richard G., Lehenbauer, Kyle, Piayda, Kerstin, Pracoń, Radoslaw, Jackson, Gregory G., Flores-Umanzor, Eduardo, Faroux, Laurent, Korsholm, Kasper, Chun, Julian K.R., Chen, Shaojie, Maarse, Moniek, Montrella, Kristi, Chaker, Zakeih, Spoon, Jocelyn N., Pastormerlo, Luigi E., Meincke, Felix, Sawant, Abhishek C., Moldovan, Carmen M., Qintar, Mohammed, Aktas, Mehmet K., Branca, Luca, Radinovic, Andrea, Ram, Pradhum, El-Zein, Rayan S., Flautt, Thomas, Ding, Wern Yew, Sayegh, Bassel, Benito-González, Tomás, Lee, Oh-Hyun, Badejoko, Solomon O., Paitazoglou, Christina, Karim, Nabeela, Zaghloul, Ahmed M., Agrawal, Himanshu, Kaplan, Rachel M., Alli, Oluseun, Ahmed, Aamir, Suradi, Hussam S., Knight, Bradley P., Alla, Venkata M., Panaich, Sidakpal S., Wong, Tom, Bergmann, Martin W., Chothia, Rashaad, Kim, Jung-Sun, Pérez de Prado, Armando, Bazaz, Raveen, Gupta, Dhiraj, Valderrabano, Miguel, Sanchez, Carlos E., El Chami, Mikhael F., Mazzone, Patrizio, Adamo, Marianna, Ling, Fred, Wang, Dee Dee, O’Neill, William, Wojakowski, Wojtek, Pershad, Ashish, Berti, Sergio, Spoon, Daniel, Kawsara, Akram, Jabbour, George, Boersma, Lucas V.A., Schmidt, Boris, Nielsen-Kudsk, Jens Erik, Rodés-Cabau, Josep, Freixa, Xavier, Ellis, Christopher R., Fauchier, Laurent, Demkow, Marcin, Sievert, Horst, Main, Michael L., Hibbert, Benjamin, Holmes, David R., Jr., and Alkhouli, Mohamad

Published
2021
Full Text
View/download PDF

27. The role of Matrix Metalloproteinase-2 and Galectin-3 as predictive biomarkers for all-cause mortality in patients undergoing transfemoral transcatheter aortic valve implantation.

Author

Piayda, Kerstin, Heilemann, Julian Tim, Keranov, Stanislav, Schulz, Luisa, Arsalan, Mani, Liebetrau, Christoph, Kim, Won-Keun, Hofmann, Felix J., Bauer, Pascal, Voss, Sandra, Troidl, Christian, Sossalla, Samuel T., Hamm, Christian W., Nef, Holger M., and Dörr, Oliver

Subjects
*HEART valve prosthesis implantation, *GALECTINS, *MORTALITY, *DISEASE risk factors, *AORTIC stenosis, *ARTIFICIAL knees
Abstract

Currently available risk scores fail to accurately predict morbidity and mortality in patients with severe symptomatic aortic stenosis who undergo transcatheter aortic valve implantation (TAVI). In this context, biomarkers like matrix metalloproteinase-2 (MMP-2) and Galectin-3 (Gal-3) may provide additional prognostic information. Patients with severe aortic stenosis undergoing consecutive, elective, transfemoral TAVI were included. Baseline demographic data, functional status, echocardiographic findings, clinical outcomes and biomarker levels were collected and analysed. The study cohort consisted of 89 patients (age 80.4 ± 5.1 years, EuroScore II 7.1 ± 5.8%). During a median follow-up period of 526 d, 28 patients (31.4%) died. Among those who died, median baseline MMP-2 (alive: 221.6 [170.4; 263] pg/mL vs. deceased: 272.1 [225; 308.8] pg/mL, p < 0.001) and Gal-3 levels (alive: 19.1 [13.5; 24.6] pg/mL vs. deceased: 25 [17.6; 29.5] pg/mL, p = 0.006) were higher than in survivors. In ROC analysis, MMP-2 reached an acceptable level of discrimination to predict mortality (AUC 0.733, 95% CI [0.62; 0.83], p < 0.001), but the predictive value of Gal-3 was poor (AUC 0.677, 95% CI [0.56; 0.79], p = 0.002). Kaplan–Meier and Cox regression analyses showed that patients with MMP-2 and Gal-3 concentrations above the median at baseline had significantly impaired long-term survival (p = 0.004 and p = 0.02, respectively). In patients with severe aortic stenosis undergoing transfemoral TAVI, MMP-2 and to a lesser extent Gal-3, seem to have additive value in optimizing risk prediction and streamlining decision-making. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure

Author

Mesnier, Jules, primary, Simard, Trevor, additional, Jung, Richard G., additional, Lehenbauer, Kyle R., additional, Piayda, Kerstin, additional, Pracon, Radoslaw, additional, Jackson, Gregory G., additional, Flores-Umanzor, Eduardo, additional, Faroux, Laurent, additional, Korsholm, Kasper, additional, Chun, Julian K.R., additional, Chen, Shaojie, additional, Maarse, Moniek, additional, Montrella, Kristi, additional, Chaker, Zakeih, additional, Spoon, Jocelyn N., additional, Pastormerlo, Luigi E., additional, Meincke, Felix, additional, Sawant, Abhishek C., additional, Moldovan, Carmen M., additional, Qintar, Mohammed, additional, Aktas, Mehmet K., additional, Branca, Luca, additional, Radinovic, Andrea, additional, Ram, Pradhum, additional, El-Zein, Rayan S., additional, Flautt, Thomas, additional, Ding, Wern Yew, additional, Sayegh, Bassel, additional, Benito-González, Tomás, additional, Lee, Oh-Hyun, additional, Badejoko, Solomon O., additional, Paitazoglou, Christina, additional, Karim, Nabeela, additional, Zaghloul, Ahmed M., additional, Agarwal, Himanshu, additional, Kaplan, Rachel M., additional, Alli, Oluseun, additional, Ahmed, Aamir, additional, Suradi, Hussam S., additional, Knight, Bradley P., additional, Alla, Venkata M., additional, Panaich, Sidakpal S., additional, Wong, Tom, additional, Bergmann, Martin W., additional, Chothia, Rashaad, additional, Kim, Jung-Sun, additional, Pérez de Prado, Armando, additional, Bazaz, Raveen, additional, Gupta, Dhiraj, additional, Valderrábano, Miguel, additional, Sanchez, Carlos E., additional, El Chami, Mikhael F., additional, Mazzone, Patrizio, additional, Adamo, Marianna, additional, Ling, Fred, additional, Wang, Dee Dee, additional, O’Neill, William, additional, Wojakowski, Wojtek, additional, Pershad, Ashish, additional, Berti, Sergio, additional, Spoon, Daniel B., additional, Kawsara, Akram, additional, Jabbour, George, additional, Boersma, Lucas V.A., additional, Schmidt, Boris, additional, Nielsen-Kudsk, Jens Erik, additional, Freixa, Xavier, additional, Ellis, Christopher R., additional, Fauchier, Laurent, additional, Demkow, Marcin, additional, Sievert, Horst, additional, Main, Michael L., additional, Hibbert, Benjamin, additional, Holmes, David R., additional, Alkhouli, Mohamad, additional, and Rodés-Cabau, Josep, additional

Published
2023
Full Text
View/download PDF

32. Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge‐to‐edge repair ‐ Results from TriValve Registry

Author

Russo, Giulio, primary, Badano, Luigi P, additional, Adamo, Marianna, additional, Alessandrini, Hannes, additional, Andreas, Martin, additional, Braun, Daniel, additional, Connelly, Kim A., additional, Denti, Paolo, additional, Estevez‐Loureiro, Rodrigo, additional, Fam, Neil, additional, Gavazzoni, Mara, additional, Hahn, Rebecca T., additional, Harr, Claudia, additional, Hausleiter, Joerg, additional, Himbert, Dominique, additional, Kalbacher, Daniel, additional, Ho, Edwin, additional, Latib, Azeem, additional, Lubos, Edith, additional, Ludwig, Sebastian, additional, Lurz, Philipp, additional, Monivas, Vanessa, additional, Nickenig, Georg, additional, Pedicino, Daniela, additional, Pedrazzini, Giovanni, additional, Pozzoli, Alberto, additional, Pires Marafon, Denise, additional, Pastorino, Roberta, additional, Praz, Fabien, additional, Rodes‐Cabau, Joseph, additional, Besler, Christian, additional, Schofer, Joachim, additional, Scotti, Andrea, additional, Piayda, Kerstin, additional, Sievert, Horst, additional, Tang, Gilbert H.L., additional, Thiele, Holger, additional, Schlotter, Florian, additional, von Bardeleben, Ralph Stephan, additional, Webb, John, additional, Windecker, Stephan, additional, Leon, Martin, additional, Maisano, Francesco, additional, Metra, Marco, additional, and Taramasso, Maurizio, additional

Published
2023
Full Text
View/download PDF

33. TCT-480 Severe Aortic Stenosis and Concomitant Complex, High-Risk PCI: Current Management and Survival in Large Volume Centers

Author

Montalto, Claudio, primary, Regazzoli, Damiano, additional, Arslani, Ketina, additional, Brunner, Stephanie, additional, Mangieri, Antonio, additional, Verhemel, Sarah, additional, Buono, Andrea, additional, Squillace, Mattia, additional, Diez-Gil, Jose L., additional, Foroni, Marco, additional, Mandurino-Mirizzi, Alessandro, additional, Bauer, Dávid, additional, Piayda, Kerstin, additional, Sievert, Kolja, additional, Zecchino, Simone, additional, de Ornelas, Benjamin, additional, Esposito, Giuseppe, additional, Munafò, Andrea, additional, Cozzi, Ottavia, additional, Nava, Stefano, additional, Bruschi, Giuseppe, additional, Porto, Italo, additional, Kornowski, Ran, additional, Toušek, Petr, additional, Fischetti, Dionigi, additional, Maffeo, Diego, additional, Bedogni, Francesco, additional, Sanchez, Jorge Sanz, additional, Sievert, Horst, additional, Saia, Francesco, additional, Van Mieghem, Nicolas, additional, Toggweiler, Stefan, additional, and De Backer, Ole, additional

Published
2023
Full Text
View/download PDF

34. Left Atrial Appendage Occlusion With Watchman® Device in Patients With Non-Valvular Atrial Fibrillation and End-Stage Chronic Kidney Disease on Hemodialysis (EPIC06 - WATCH-HD)

Author

Benito-González, Tomás, primary, Ellis, Christopher, additional, Sawant, Abhishek, additional, Jabbour, George, additional, Torres-Saura, Francisco, additional, Suradi, Hussam, additional, Cruz-Gonzalez, Ignacio, additional, D'Angelo, Giuseppe, additional, Ruiz-Nodar, Juan, additional, Valero, Ernesto, additional, Alli, Seun, additional, Pershad, Ashish, additional, Nielsen-Kudsk, Jens Erik, additional, Adamo, Marianna, additional, Bazaz, Raveen, additional, Perez, German Calle, additional, Piayda, Kerstin, additional, El Chami, Mikhael, additional, Agarwal, Himanshu, additional, Sanchez, Carlos, additional, Estevez-Loureiro, Rodrigo, additional, Millán, Xavier, additional, Aktas, Mehmet, additional, and de Prado, Armando Pérez, additional

Published
2023
Full Text
View/download PDF

38. PO-03-189 THROMBOEMBOLISM BEFORE VS AFTER PERCUTANEOUS CLOSURE OF PERI-DEVICE LEAKS RESULTING FROM PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION

Author

Della Rocca, Domenico G., primary, Horton, Rodney P., additional, Magnocavallo, Michele, additional, King, Nicholas, additional, Turagam, Mohit, additional, Piayda, Kerstin, additional, Kramer, Anders Dahl, additional, Killu, Ammar M., additional, Galea, Roberto, additional, Jackson, Gregory, additional, Kawamura, Iwanari, additional, Kanagasundram, Arvindh N., additional, Ekanem, Emmanuel, additional, Bertog, Stefan, additional, Chierchia, Gian Battista, additional, de Asmundis, Carlo, additional, Korsholm, Kasper, additional, Sievert, Kolja, additional, Gianni, Carola, additional, Simard, Trevor, additional, Räber, Lorenz, additional, Alkhouli, Mohamad A., additional, Holmes, David R., additional, Nielsen-Kudsk, Jens Erik, additional, Sievert, Horst, additional, Reddy, Vivek Y., additional, Ellis, Christopher R., additional, and Natale, Andrea, additional

Published
2023
Full Text
View/download PDF

40. Symptomatic vs. non-symptomatic device-related thrombus after LAAC:a sub-analysis from the multicenter EUROC-DRT registry

Author

Vij, Vivian, Cruz-González, Ignacio, Galea, Roberto, Piayda, Kerstin, Nelles, Dominik, Vogt, Lara, Gloekler, Steffen, Fürholz, Monika, Meier, Bernhard, Räber, Lorenz, O'Hara, Gilles, Arzamendi, Dabit, Agudelo, Victor, Asmarats, Lluis, Freixa, Xavier, Flores-Umanzor, Eduardo, De Backer, Ole, Sondergaard, Lars, Nombela-Franco, Luis, McInerney, Angela, Salinas, Pablo, Korsholm, Kasper, Nielsen-Kudsk, Jens Erik, Afzal, Shazia, Zeus, Tobias, Operhalski, Felix, Schmidt, Boris, Montalescot, Gilles, Guedeney, Paul, Iriart, Xavier, Miton, Noelie, Saw, Jacqueline, Gilhofer, Thomas, Fauchier, Laurent, Veliqi, Egzon, Meincke, Felix, Petri, Nils, Nordbeck, Peter, Gonzalez-Ferreiro, Rocio, Bhatt, Deepak L, Laricchia, Alessandra, Mangieri, Antonio, Omran, Heyder, Schrickel, Jan Wilko, Rodes-Cabau, Josep, Nickenig, Georg, Sievert, Horst, and Sedaghat, Alexander

Abstract

BACKGROUND: Device-related thrombus (DRT) after left atrial appendage closure (LAAC) is associated with adverse outcomes, i.e. ischemic stroke or systemic embolism (SE). Data on predictors of stroke/SE in the context of DRT are limited.AIMS: This study aimed to identify predisposing factors for stroke/SE in DRT patients. In addition, the temporal connection of stroke/SE to DRT diagnosis was analyzed.METHODS: The EUROC-DRT registry included 176 patients, in whom DRT after LAAC were diagnosed. Patients with symptomatic DRT, defined as stroke/SE in the context of DRT diagnosis, were compared against patients with non-symptomatic DRT. Baseline characteristics, anti-thrombotic regimens, device position, and timing of stroke/SE were compared.RESULTS: Stroke/SE occurred in 25/176 (14.2%) patients diagnosed with DRT (symptomatic DRT). Stroke/SE occurred after a median of 198 days (IQR 37-558) after LAAC. In 45.8% stroke/SE occurred within one month before/after DRT diagnosis (DRT-related stroke). Patients with symptomatic DRT had lower left ventricular ejection fractions (50.0 ± 9.1% vs. 54.2 ± 11.0%, p = 0.03) and higher rates of non-paroxysmal atrial fibrillation (84.0% vs. 64.9%, p = 0.06). Other baseline parameters and device positions were not different. Most ischemic events occurred among patients with single antiplatelet therapy (50%), however, stroke/SE was also observed under dual antiplatelet therapy (25%) or oral anticoagulation (20%).CONCLUSION: Stroke/SE are documented in 14.2% and occur both in close temporal relation to the DRT finding and chronologically independently therefrom. Identification of risk factors remains cumbersome, putting all DRT patients at substantial risk for stroke/SE. Further studies are necessary to minimize the risk of DRT and ischemic events.

Published
2023

41. Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review

Author

Kodeboina, Monika, primary, Piayda, Kerstin, additional, Jenniskens, Inge, additional, Vyas, Pearl, additional, Chen, Sara, additional, Pesigan, Ramon Julian, additional, Ferko, Nicole, additional, Patel, Barkha P., additional, Dobrin, Annamaria, additional, Habib, Jayson, additional, and Franke, Jennifer, additional

Published
2023
Full Text
View/download PDF

42. Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications

Author

Landes, Uri, primary, Hochstadt, Aviram, additional, Manevich, Lisa, additional, Webb, John G, additional, Sathananthan, Janarthanan, additional, Sievert, Horst, additional, Piayda, Kerstin, additional, Leon, Martin B, additional, Nazif, Tamim M, additional, Blusztein, David, additional, Hildick-Smith, David, additional, Pavitt, Chris, additional, Thiele, Holger, additional, Abdel-Wahab, Mohamed, additional, Van Mieghem, Nicolas M, additional, Adrichem, Rik, additional, Sondergaard, Lars, additional, De Backer, Ole, additional, Makkar, Raj R, additional, Koren, Ofir, additional, Pilgrim, Thomas, additional, Okuno, Taishi, additional, Kornowski, Ran, additional, Codner, Pablo, additional, Finkelstein, Ariel, additional, Loewenstein, Itamar, additional, Barbash, Israel, additional, Sharon, Amir, additional, De Marco, Federico, additional, Montorfano, Matteo, additional, Buzzatti, Nicola, additional, Latib, Azeem, additional, Scotti, Andrea, additional, Kim, Won-Keun, additional, Hamm, Christian, additional, Franco, Luis Nombela, additional, Mangieri, Antonio, additional, Schoels, Wolfgang H, additional, Barbanti, Marco, additional, Bunc, Matjaz, additional, Akodad, Myriama, additional, Rubinshtein, Ronen, additional, and Danenberg, Haim, additional

Published
2023
Full Text
View/download PDF

43. CRT-700.55 Left Atrial Appendage Occlusion With Watchman® Device in Patients With Non-Valvular Atrial Fibrillation and End-Stage Chronic Kidney Disease on Hemodialysis (EPIC06 - WATCH-HD)

Author

Benito-González, Tomás, primary, Ellis, Christopher, additional, Sawant, Abhishek, additional, Jabbour, George, additional, Torres-Saura, Francisco, additional, Suradi, Hussam, additional, Cruz-Gonzalez, Ignacio, additional, D'Angelo, Giuseppe, additional, Ruiz-Nodar, Juan, additional, Valero, Ernesto, additional, Alli, Seun, additional, Pershad, Ashish, additional, Nielsen-Kudsk, Jens Erik, additional, Adamo, Marianna, additional, Bazaz, Raveen, additional, Perez, German Calle, additional, Piayda, Kerstin, additional, El Chami, Mikhael, additional, Agarwal, Himanshu, additional, Sanchez, Carlos, additional, Estevez-Loureiro, Rodrigo, additional, Millán, Xavier, additional, Aktas, Mehmet, additional, and Pérez de Prado, Armando, additional

Published
2023
Full Text
View/download PDF

44. Transcatheter Interventions for Atrioventricular Dysfunction in Patients with Adult Congenital Heart Disease:An International Case Series

Author

Schamroth Pravda, Nili, Vaknin Assa, Hana, Sondergaard, Lars, Bajoras, Vilhelmas, Sievert, Horst, Piayda, Kerstin, Levi, Amos, Witberg, Guy, Shapira, Yaron, Hamdan, Ashraf, Perl, Leor, Vig, Shahar, Blieden, Leonard, Kornowski, Ran, Hirsch, Rafael, Codner, Pablo, Schamroth Pravda, Nili, Vaknin Assa, Hana, Sondergaard, Lars, Bajoras, Vilhelmas, Sievert, Horst, Piayda, Kerstin, Levi, Amos, Witberg, Guy, Shapira, Yaron, Hamdan, Ashraf, Perl, Leor, Vig, Shahar, Blieden, Leonard, Kornowski, Ran, Hirsch, Rafael, and Codner, Pablo

Abstract

Introduction: A substantial proportion of patients with adult congenital heart disease (ACHD) suffer from worsening valvular dysfunction in adulthood. Transcatheter valve interventions can offer a therapeutic alternative to surgery for those at high surgical risk. There is emerging but limited data on transcatheter interventions for atrioventricular (AV) valve dysfunction in patients with ACHD. Methods: We compiled an international collaborative multi-center registry focusing on adult patients with congenital heart disease undergoing transcatheter AV valve interventions (repair or replacement). Included were patients from three international centers who underwent procedures between 2016 and 2022. Demographic, clinical, and procedural data were compiled. Results: Nine patients with ACHD underwent AV valve interventions. The median age was 48 years (IQR (37; 56), 55% women). At baseline, seven patients (78%) were in NYHA functional class III and two (22%) were in NYHA functional class II. The diagnosis of ACHD varied. Three valve interventions were performed on the subpulmonary AV valve and six on the systemic AV valve. The primary valvular pathology was regurgitation (six patients, 78%). Five procedures were valve-in-valve interventions, and four procedures were transcatheter edge-to-edge repair procedures. There were no major complications or peri-procedural complications or peri-procedural mortality. One patient developed a suspected non-obstructive thrombus on the valve that was medically treated. One patient did not improve clinically following the procedure and underwent a heart transplant, one patient died 6 months following the procedure due to a cardiovascular implantable electronic device infection. At one year, six patients were in NYHA functional class I, and one patient was in NYHA functional class III. In conclusion, transcatheter AV heart valve interventions are feasible and safe procedures in carefully selected ACHD patients. These procedures can offer, Introduction: A substantial proportion of patients with adult congenital heart disease (ACHD) suffer from worsening valvular dysfunction in adulthood. Transcatheter valve interventions can offer a therapeutic alternative to surgery for those at high surgical risk. There is emerging but limited data on transcatheter interventions for atrioventricular (AV) valve dysfunction in patients with ACHD. Methods: We compiled an international collaborative multi-center registry focusing on adult patients with congenital heart disease undergoing transcatheter AV valve interventions (repair or replacement). Included were patients from three international centers who underwent procedures between 2016 and 2022. Demographic, clinical, and procedural data were compiled. Results: Nine patients with ACHD underwent AV valve interventions. The median age was 48 years (IQR (37; 56), 55% women). At baseline, seven patients (78%) were in NYHA functional class III and two (22%) were in NYHA functional class II. The diagnosis of ACHD varied. Three valve interventions were performed on the subpulmonary AV valve and six on the systemic AV valve. The primary valvular pathology was regurgitation (six patients, 78%). Five procedures were valve-in-valve interventions, and four procedures were transcatheter edge-to-edge repair procedures. There were no major complications or peri-procedural complications or peri-procedural mortality. One patient developed a suspected non-obstructive thrombus on the valve that was medically treated. One patient did not improve clinically following the procedure and underwent a heart transplant, one patient died 6 months following the procedure due to a cardiovascular implantable electronic device infection. At one year, six patients were in NYHA functional class I, and one patient was in NYHA functional class III. In conclusion, transcatheter AV heart valve interventions are feasible and safe procedures in carefully selected ACHD patients. These procedures can of

Published
2023

45. Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR-A multicenter experience

Author

Al-Kassou, Baravan, Veulemans, Verena, Shamekhi, Jasmin, Maier, Oliver, Piayda, Kerstin, Zeus, Tobias, Aksoy, Adem, Zietzer, Andreas, Meertens, Max, Mauri, Victor, Weber, Marcel, Sinning, Jan-Malte, Grube, Eberhard, Adam, Matti, Bakhtiary, Farhad, Zimmer, Sebastian, Baldus, Stephan, Kelm, Malte, Nickenig, Georg, Sedaghat, Alexander, Al-Kassou, Baravan, Veulemans, Verena, Shamekhi, Jasmin, Maier, Oliver, Piayda, Kerstin, Zeus, Tobias, Aksoy, Adem, Zietzer, Andreas, Meertens, Max, Mauri, Victor, Weber, Marcel, Sinning, Jan-Malte, Grube, Eberhard, Adam, Matti, Bakhtiary, Farhad, Zimmer, Sebastian, Baldus, Stephan, Kelm, Malte, Nickenig, Georg, and Sedaghat, Alexander

Abstract

Background Despite major advances, transcatheter aortic valve replacement (TAVR) is still associated with procedure-specific complications. Although previous studies reported lower bleeding rates in patients receiving protamine for heparin reversal, the optimal protamine-to-heparin dosing ratio is unknown. Hypothesis The aim of this study was a comparison of two different heparin antagonization regimens for the prevention of bleeding complications after TAVR. Methods The study included 1446 patients undergoing TAVR, of whom 623 received partial and 823 full heparin antagonization. The primary endpoint was a composite of 30-day mortality, life-threatening, and major bleeding. Safety endpoints included stroke and myocardial infarction at 30 days. Results Full antagonization of heparin resulted in lower rates of the primary endpoint as compared to partial heparin reversal (5.6% vs. 10.4%, p < .01), which was mainly driven by lower rates of life-threatening (0.5% vs. 1.6%, p = .05) and major bleeding (3.2% vs. 7.5%, p < .01). Moreover, the incidence of major vascular complications was significantly lower in patients with full heparin reversal (3.5% vs. 7.5%, p < .01). The need for red-blood-cell transfusion was lower in patients receiving full as compared to partial heparin antagonization (10.4% vs. 15.9%, p < .01). No differences were observed in the incidence of stroke and myocardial infarction between patients with full and partial heparin reversal (2.2% vs. 2.6%, p = .73 and 0.2% vs. 0.4%, p = .64, respectively). Conclusions Full heparin antagonization resulted in significantly lower rates of life-threatening and major bleeding after TAVR as compared to partial heparin reversal. The occurrence of stroke and myocardial infarction was low and comparable between both groups.

Published
2023

46. Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation:prognostic implications

Author

Landes, Uri, Hochstadt, Aviram, Manevich, Lisa, Webb, John G., Sathananthan, Janarthanan, Sievert, Horst, Piayda, Kerstin, Leon, Martin B., Nazif, Tamim M., Blusztein, David, Hildick-Smith, David, Pavitt, Chris, Thiele, Holger, Abdel-Wahab, Mohamed, Van Mieghem, Nicolas M., Adrichem, Rik, Sondergaard, Lars, De Backer, Ole, Makkar, Raj R., Koren, Ofir, Pilgrim, Thomas, Okuno, Taishi, Kornowski, Ran, Codner, Pablo, Finkelstein, Ariel, Loewenstein, Itamar, Barbash, Israel, Sharon, Amir, De Marco, Federico, Montorfano, Matteo, Buzzatti, Nicola, Latib, Azeem, Scotti, Andrea, Kim, Won Keun, Hamm, Christian, Franco, Luis Nombela, Mangieri, Antonio, Schoels, Wolfgang H., Barbanti, Marco, Bunc, Matjaz, Akodad, Myriama, Rubinshtein, Ronen, Danenberg, Haim, Landes, Uri, Hochstadt, Aviram, Manevich, Lisa, Webb, John G., Sathananthan, Janarthanan, Sievert, Horst, Piayda, Kerstin, Leon, Martin B., Nazif, Tamim M., Blusztein, David, Hildick-Smith, David, Pavitt, Chris, Thiele, Holger, Abdel-Wahab, Mohamed, Van Mieghem, Nicolas M., Adrichem, Rik, Sondergaard, Lars, De Backer, Ole, Makkar, Raj R., Koren, Ofir, Pilgrim, Thomas, Okuno, Taishi, Kornowski, Ran, Codner, Pablo, Finkelstein, Ariel, Loewenstein, Itamar, Barbash, Israel, Sharon, Amir, De Marco, Federico, Montorfano, Matteo, Buzzatti, Nicola, Latib, Azeem, Scotti, Andrea, Kim, Won Keun, Hamm, Christian, Franco, Luis Nombela, Mangieri, Antonio, Schoels, Wolfgang H., Barbanti, Marco, Bunc, Matjaz, Akodad, Myriama, Rubinshtein, Ronen, and Danenberg, Haim

Abstract

Aims Paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) is associated with increased morbidity and mortality. The effect of transcatheter interventions to treat PVR after the index TAVI was investigated. Methods and results A registry of consecutive patients who underwent transcatheter intervention for ≥ moderate PVR after the index TAVI at 22 centers. The principal outcomes were residual aortic regurgitation (AR) and mortality at 1 year after PVR treatment. A total of 201 patients were identified: 87 (43%) underwent redo-TAVI, 79 (39%) plug closure, and 35 (18%) balloon valvuloplasty. Median TAVI-to-re-intervention time was 207 (35; 765) days. The failed valve was self-expanding in 129 (63.9%) patients. The most frequent devices utilized were a Sapien 3 valve for redo-TAVI (55, 64%), an AVP II as plug (33, 42%), and a True balloon for valvuloplasty (20, 56%). At 30 days, AR ≥ moderate persisted in 33 (17.4%) patients: 8 (9.9%) after redo-TAVI, 18 (25.9%) after plug, and 7 (21.9%) after valvuloplasty (P = 0.036). Overall mortality was 10 (5.0%) at 30 days and 29 (14.4%) at 1 year: 0, 8 (10.1%), and 2 (5.7%) at 30 days (P = 0.010) and 11 (12.6%), 14 (17.7%), and 4 (11.4%) at 1 year (P = 0.418), after redo-TAVI, plug, and valvuloplasty, respectively. Regardless of treatment strategy, patients in whom AR was reduced to ≤ mild had lower mortality at 1 year compared with those with AR persisting ≥ moderate [11 (8.0%) vs. 6 (21.4%); P = 0.007]. Conclusion This study describes the efficacy of transcatheter treatments for PVR after TAVI. Patients in whom PVR was successfully reduced had better prognosis. The selection of patients and the optimal PVR treatment modality require further investigation., Aims Paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) is associated with increased morbidity and mortality. The effect of transcatheter interventions to treat PVR after the index TAVI was investigated. Methods A registry of consecutive patients who underwent transcatheter intervention for ≥ moderate PVR after the index TAVI at 22 and results centers. The principal outcomes were residual aortic regurgitation (AR) and mortality at 1 year after PVR treatment. A total of 201 patients were identified: 87 (43%) underwent redo-TAVI, 79 (39%) plug closure, and 35 (18%) balloon valvuloplasty. Median TAVI-to-re-intervention time was 207 (35; 765) days. The failed valve was self-expanding in 129 (63.9%) patients. The most frequent devices utilized were a Sapien 3 valve for redo-TAVI (55, 64%), an AVP II as plug (33, 42%), and a True balloon for valvuloplasty (20, 56%). At 30 days, AR ≥ moderate persisted in 33 (17.4%) patients: 8 (9.9%) after redo-TAVI, 18 (25.9%) after plug, and 7 (21.9%) after valvuloplasty (P = 0.036). Overall mortality was 10 (5.0%) at 30 days and 29 (14.4%) at 1 year: 0, 8 (10.1%), and 2 (5.7%) at 30 days (P = 0.010) and 11 (12.6%), 14 (17.7%), and 4 (11.4%) at 1 year (P = 0.418), after redo-TAVI, plug, and valvuloplasty, respectively. Regardless of treatment strategy, patients in whom AR was reduced to ≤ mild had lower mortality at 1 year compared with those with AR persisting ≥ moderate [11 (8.0%) vs. 6 (21.4%); P = 0.007]. Conclusion This study describes the efficacy of transcatheter treatments for PVR after TAVI. Patients in whom PVR was successfully reduced had better prognosis. The selection of patients and the optimal PVR treatment modality require further investigation.

Published
2023

47. Rational and design of the REMOTE trial: An exploratory, pilot study to analyze REtinal MicrOcirculaTion in wEightlessness

Author

Binneboessel, Stephan, primary, Masyuk, Maryna, additional, Piayda, Kerstin, additional, Bruno, Raphael Romano, additional, Wernly, Bernhard, additional, Jirak, Peter, additional, Wolff, Georg, additional, Gerdes, Norbert, additional, Baldia, Philipp Heinrich, additional, Kelm, Malte, additional, Nienhaus, Fabian, additional, Lang, Alexander, additional, Winkels, Holger, additional, Geerling, Gerd, additional, Guthoff, Rainer, additional, Kaya, Sema, additional, Flossmann, Gerald, additional, Riemer, Thomas, additional, Baertschi, Michael, additional, and Jung, Christian, additional

Published
2023
Full Text
View/download PDF

48. Transcatheter Interventions for Atrioventricular Dysfunction in Patients with Adult Congenital Heart Disease: An International Case Series

Author

Schamroth Pravda, Nili, primary, Vaknin Assa, Hana, additional, Sondergaard, Lars, additional, Bajoras, Vilhelmas, additional, Sievert, Horst, additional, Piayda, Kerstin, additional, Levi, Amos, additional, Witberg, Guy, additional, Shapira, Yaron, additional, Hamdan, Ashraf, additional, Perl, Leor, additional, Vig, Shahar, additional, Blieden, Leonard, additional, Kornowski, Ran, additional, Hirsch, Rafael, additional, and Codner, Pablo, additional

Published
2023
Full Text
View/download PDF

49. Tricuspid Valve Repair by Chordal Grasping

Author

Danenberg, Haim D., primary, Topilsky, Yan, additional, Planer, David, additional, Maor, Elad, additional, Guetta, Victor, additional, Sievert, Horst, additional, Hausleiter, Jörg, additional, Carmel, Chani, additional, Piayda, Kerstin, additional, Flint, Nir, additional, Yaron, Dana, additional, and Beeri, Ronen, additional

Published
2023
Full Text
View/download PDF

50. First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy

Author

Wang, Zihao, primary, Zhao, Rong, additional, Sievert, Horst, additional, Ta, Shengjun, additional, Li, Jing, additional, Bertog, Stefan, additional, Piayda, Kerstin, additional, Zhou, Mengyao, additional, Lei, Changhui, additional, Li, Xiaojuan, additional, Liu, Jiani, additional, Xu, Bo, additional, Feng, Bo, additional, Hu, Rui, additional, and Liu, Liwen, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results